About Phoenix ST
Phoenix ST is a Technology company based in Chester Heights (United States) founded in 2001. It operates as a nano microspray solutions for research drug delivery applications. It operates in the Technology and Healthcare sectors. Phoenix ST has raised $1.3 million across 9 funding rounds from investors including HHS and BioAdvance. Its focus areas include High Tech, Nanotechnology, Nanoenabled Products and Life Science. Its competitors include Biological Dynamics, Sirnaomics, Liquidia, Acorda and Genedit and 6 more; 10 of its 11 listed competitors have raised funding.
Company details
Phoneix-St provides patented and patent-pending nano micro spray solutions for research applications. Offers 3-D microfluidic devices based on microinjection molding of plastics for highly flexible designs for integration into the customers existing mass spectrometers and high-throughput robotics. Finds use cases in drug discovery, clinical diagnostics, and homeland security. Partners include US Army, University of Maryland, University of Arizona and the University of Pennsylvania Medical School.
- Headquarters Chester Heights, United States
- SectorsTechnologyHealthcare
- Email••••••••
- Website phoenix-st.com
- Social LinkedIn
- Total Equity Funding$1.3M (USD)
in 9 rounds
- Latest Funding Round$149.86K (USD), Grant
Mar 2019
- InvestorsHHS
& 1 more
Funding Insights of Phoenix ST
Phoenix ST has successfully raised a total of $1.3M across 9 strategic funding rounds. The most recent funding activity was a Grant round of $149.86 thousand completed in March 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.3M
- Total Rounds 9
- Last Round Grant — $149,857
- First Round $500,000
(Jan 2002)
- Investors Count 2
All 9 funding rounds of Phoenix ST with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2019 | $149,857 | Grant | – | – | |
| Nov 2010 | $50,000 | Seed | – | – | – |
| Jun 2010 | $50,000 | Seed | – | – | – |
| May 2009 | $799,477 | Grant | – | – | |
| Sep 2008 | $500,000 | Seed | – | – | |
| May 2008 | $799,477 | Grant | – | – | |
| May 2005 | $799,477 | Grant | – | – | |
| Jan 2002 | $200,000 | Seed | – | – | – |
| Jan 2002 | $500,000 | Seed | – | – | – |
2 investors in total: 2 institutional.
Investors in Phoenix ST
Phoenix ST has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS and BioAdvance.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
- | – | bioadvance.com | - | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - |
Investor details for Phoenix ST
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Phoenix ST
3 dated milestones of Phoenix ST across 18 years, from founding to its latest funding, stage changes and deals.
- Founded Phoenix ST is founded.
- Funding First funding round of $500K.
- Funding Latest funding round, Grant, of $150K.
Competitors of Phoenix ST
Phoenix ST has 11 listed competitors in our database, 10 of them funded. They include Biological Dynamics, Sirnaomics, Liquidia, Acorda and Genedit, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| biologicaldynamics.com | 2010 | San Diego, United States | $67.65M | 54 | Proprietary lab-on-chip platform for nanoparticle isolation is offered. | |
| sirnaomics.com | 2007 | Gaithersburg, United States | $267M | 88 | RNA-based therapeutics for cancer and fibrosis are developed. | |
| liquidia.com | 2004 | United States | $75.3M | 63 | Engineered particles & films for life and material sciences applications | |
| acorda.com | 1995 | Ardsley, United States | $66.5M | 109 | Engaged in the development and commercialization of therapies that improve neurological function. | |
| genedit.com | 2016 | Berkeley, United States | $93.5M | 34 | Genetic medicines are delivered using polymer nanoparticle platforms. | |
| anteotech.com | 1995 | Eight Mile Plains, Australia | – | – | Coupling reagents are developed for biomolecules immobilization on surfaces. | |
| nanosyrinx.com | 2018 | Coventry, United Kingdom | $21.63M | 17 | Drug delivery systems to cell interiors are developed via nanosyringes. | |
| midiagnostics.com | 2015 | Leuven, Belgium | $112.75M | 93 | Disposable chips are developed for rapid point-of-care blood diagnostics. | |
| ensysce.com | 2008 | Houston, United States | $2.5M | – | Drug delivery solutions via single-walled carbon nanotubes are offered. | |
| arcturusrx.com | 2013 | San Diego, United States | $1.3M | 337 | RNAi technologies are developed for treating rare orphan diseases. |
Detailed competitors of Phoenix ST
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Phoenix ST
Websites that share an audience with Phoenix ST (phoenix-st.com).
Websites whose visitors overlap most with Phoenix ST. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| bioanalyte.com | 100% | – | – | View details | |
fiehnlab.ucdavis.edu | fiehnlab.ucdavis.edu | 98% | – | – | – |
| newobjective.com | 98% | – | – | View details | |
| spectralworks.com | 98% | – | #6,804,801 | View details | |
bruker.co.uk | bruker.co.uk | 97% | – | – | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 19 similar websites and full traffic analytics for Phoenix ST
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 19 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Nanotechnology
10 companies that operate in the same segment as Phoenix ST (Nanotechnology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Developer of technologies for analysis of genetic variation and function | 1993 | San Diego, California, United States | USD 28 M | USD 1.44 M | 29 | |
RNA interference-based therapeutics are developed for multiple disorders. | 2002 | Cambridge, Massachusetts, United States | USD 17 M | USD 3.71 B | 2,230 | |
Technology tools and systems for molecular scale are developed. | 1959 | Abingdon, Oxfordshire, United Kingdom | – | USD 648.1 M | – | |
Aerogel-based thermal insulation solutions are provided for energy conservation. | 2001 | United States | USD 198.35 M | USD 271.1 M | 554 | |
Nanotech-based electrode materials for supercapacitors are provided. | 2009 | Boston, Massachusetts, United States | USD 163.32 M | – | 66 | |
Instrument systems and software for single-molecule real-time sequencing are developed. | 2004 | Menlo Park, California, United States | USD 395 M | USD 160 M | 575 | |
Nanotech-based wound care products are developed and provided. | 2010 | Madison, Wisconsin, United States | USD 22.7 M | – | 35 | |
Conductive nanocoatings are delivered via atomic layer deposition technology. | 2013 | Boulder, Colorado, United States | USD 202.75 M | – | – | |
RNA therapeutics for hematology and cardiovascular diseases are developed. | 1999 | London, England, United Kingdom | – | USD 559 K | 116 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Phoenix ST
Phoenix ST was founded in 2001 and raised its 1st funding round 1 year after it was founded.
Phoenix ST is headquartered in Chester Heights, United States. It is registered at Chester Heights, Pennsylvania, United States.
Phoenix ST is a funded company, having raised a total of $1.3M across 9 funding rounds to date. The company's 1st funding round was a Seed of $500K, raised on Jan 2002.
Phoneix-St provides patented and patent-pending nano micro spray solutions for research applications. Offers 3-D microfluidic devices based on microinjection molding of plastics for highly flexible designs for integration into the customers existing mass spectrometers and high-throughput robotics. Finds use cases in drug discovery, clinical diagnostics, and homeland security. Partners include US Army, University of Maryland, University of Arizona and the University of Pennsylvania Medical School.
Phoenix ST's top competitors include Sirnaomics, Arcturus Therapeutics and Acorda.
Phoenix ST has 2 investors. Key investors include HHS, and BioAdvance.